Lexaria Bioscience Corp. financial data

Symbol
LEXX, LEXXW on Nasdaq
Location
100 740 Mccurdy Road, Kelowna, British Columbia, Canada
Fiscal year end
August 31
Latest financial report
10-Q - Q1 2025 - Apr 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 994 % +4.86%
Debt-to-equity 10.8 % -7.05%
Return On Equity -112 % +16.5%
Return On Assets -100 % +15.5%
Operating Margin -1.79K % -35.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.6M shares +36.3%
Common Stock, Shares, Outstanding 17.4M shares +40.9%
Entity Public Float 40.6M USD
Common Stock, Value, Issued 17.6K USD +41.7%
Weighted Average Number of Shares Outstanding, Diluted 17.5M shares +62.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 526K USD +29.9%
Revenue from Contract with Customer, Excluding Assessed Tax 184K USD +21.6%
Research and Development Expense 5.18M USD +74.9%
General and Administrative Expense 4.73M USD +72.2%
Operating Income (Loss) -9.39M USD -76.4%
Nonoperating Income (Expense) 34K USD +123%
Net Income (Loss) Attributable to Parent -9.38M USD -72.5%
Earnings Per Share, Diluted -0.15 USD/shares -150%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.5M USD
Marketable Securities, Current 73.9K USD -15.7%
Accounts Receivable, after Allowance for Credit Loss, Current 331K USD -7.26%
Assets, Current 7.72M USD +42.6%
Property, Plant and Equipment, Net 262K USD +15.7%
Operating Lease, Right-of-Use Asset 157K USD +4.5%
Assets 8.68M USD +36.6%
Liabilities, Current 1.82M USD +2130%
Operating Lease, Liability, Noncurrent 94.4K USD
Liabilities 1.92M USD +839%
Accumulated Other Comprehensive Income (Loss), Net of Tax -118K USD -473%
Retained Earnings (Accumulated Deficit) -57M USD -19.7%
Stockholders' Equity Attributable to Parent 7.14M USD +9.57%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 6.76M USD +9.97%
Liabilities and Equity 8.68M USD +36.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.73M USD -131%
Net Cash Provided by (Used in) Financing Activities 4.35M USD +139%
Net Cash Provided by (Used in) Investing Activities -37.8K USD +5.55%
Common Stock, Shares Authorized 220M shares 0%
Common Stock, Shares, Issued 17.6M shares +41.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.58M USD +162%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.47M USD +37.5%
Deferred Tax Assets, Valuation Allowance 10.7M USD +12%
Deferred Tax Assets, Gross 10.7M USD +12%
Operating Lease, Liability 124K USD -16.9%
Payments to Acquire Property, Plant, and Equipment 24.6K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -9.48M USD -73.6%
Lessee, Operating Lease, Liability, to be Paid 142K USD -19.7%
Property, Plant and Equipment, Gross 772K USD
Operating Lease, Liability, Current 29.3K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 38.6K USD +4.17%
Lessee, Operating Lease, Liability, to be Paid, Year One 37.3K USD +108%
Lessee, Operating Lease, Liability, to be Paid, Year Three 38.9K USD +4.17%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.1K USD -79%
Additional Paid in Capital 64.2M USD +18.7%
Depreciation, Depletion and Amortization 8.73K USD
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 99.4K USD +84.3%